An update on ICU outcomes in patients after CAR T therapy: A four-year tertiary UK centre experience
Lily Scourfield(King's College Hospital NHS Foundation Trust), Victoria Metaxa(Apple (Israel)), Rohit Saha(King's College Hospital NHS Foundation Trust), Andrea Kühnl(King's College Hospital), Robin Sanderson(King's College Hospital NHS Foundation Trust), Tasneem Pirani(King's College Hospital NHS Foundation Trust), Neeraj Singh(Willis-Knighton Cancer Center)
Cited by 3
Related Papers
Genome-edited, donor-derived allogeneic anti-CD19 chimeric antigen receptor T cells in paediatric and adult B-cell acute lymphoblastic leukaemia: results of two phase 1 studies
|The Lancet|2020|366
Diagnosis of severe respiratory infections in immunocompromised patients
|Intensive Care Medicine|2020|340
Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study
|Intensive Care Medicine|2017|318
Communication and Virtual Visiting for Families of Patients in Intensive Care during the COVID-19 Pandemic: A UK National Survey
|Annals of the American Thoracic Society|2021|224
Interprofessional Shared Decision-Making in the ICU: A Systematic Review and Recommendations From an Expert Panel*
|Critical Care Medicine|2019|188